(Q38077556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

D Gonzalez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

L Fearfield

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

P Nathan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

P Tanière

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A Wallace

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

E Brown

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Marsden

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Whittaker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

700-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials

22 February 2020

cites work

1 reference

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

21 January 2018

1 reference

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

21 January 2018

1 reference

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma

21 January 2018

1 reference

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

21 January 2018

1 reference

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

21 January 2018

1 reference

RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

Analysis of BRAF mutation in primary and metastatic melanoma.

21 January 2018

1 reference

Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling

21 January 2018

1 reference

BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma

21 January 2018

1 reference

Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.

21 January 2018

1 reference

Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma.

21 January 2018

1 reference

Revised U.K. guidelines for the management of cutaneous melanoma 2010

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJD.12248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23360189%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference